student string | asked_at timestamp[s] | question string | model string | answer string | factors list |
|---|---|---|---|---|---|
richardyoung | 2026-09-10T20:57:48 | How has genetic testing changed medicine? | nvidia/nemotron-3.5-lightning:free | Genetic testing has moved from a specialized research tool to a routine part of patient care, and it's already reshaping hospital diagnostics and treatment. It helps catch hereditary diseases earlier, guides which chemotherapy or targeted therapies are most likely to work for a specific cancer, and allows doctors to ta... | [
{
"factor": "Early hereditary disease detection",
"importance": 85
},
{
"factor": "Targeted therapy guidance",
"importance": 80
},
{
"factor": "Precision medicine enablement",
"importance": 75
},
{
"factor": "Rapid newborn diagnostics",
"importance": 70
},
{
"fact... |
How has genetic testing changed medicine?
Asked by: richardyoung · Answered by: nvidia/nemotron-3.5-lightning:free · On: 2026-09-10
The model said. Genetic testing has moved from a specialized research tool to a routine part of patient care, and it's already reshaping hospital diagnostics and treatment. It helps catch hereditary diseases earlier, guides which chemotherapy or targeted therapies are most likely to work for a specific cancer, and allows doctors to tailor prevention plans for entire families at risk. In urgent cases, rapid gene testing on newborns can diagnose rare metabolic or genetic disorders within hours, enabling life-saving treatment sooner than waiting weeks for standard tests. It's also the engine behind "precision medicine," where choices about drugs, surgery, or lifestyle advice are based on a patient's genetic profile rather than a one-size-fits-all approach. However, results aren't always clear-cut, insurance coverage can be inconsistent, and hospitals must carefully manage privacy, consent, and potential discrimination risks. Overall, genetic testing is making medicine more proactive and personalized, but it works best when integrated thoughtfully into existing clinical pathways rather than used as a standalone shortcut.
The five factors behind it, as the model listed them (a rough ranking, not measured data):
| Factor | Importance (0 to 100) |
|---|---|
| Early hereditary disease detection | 85 |
| Targeted therapy guidance | 80 |
| Precision medicine enablement | 75 |
| Rapid newborn diagnostics | 70 |
| Family risk stratification | 65 |
One row in result.jsonl, the factors in factors.csv. The smallest version of every lab in
MIS 752: ask a model, get a result, turn it into data and a picture, publish it under your own name.
- Downloads last month
- 40